- Home
- NTHI vs RDZN Comparison
NTHI vs RDZN Comparison
Compare NTHI & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTHI | RDZN |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 104.8M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NTHI | RDZN |
|---|---|---|
| Price | $3.35 | $1.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 179.9K | ★ 322.6K |
| Earning Date | 05-19-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.12 |
| EPS | N/A | ★ N/A |
| Revenue | $39,990.00 | ★ $55,021,792.00 |
| Revenue This Year | N/A | $33.77 |
| Revenue Next Year | N/A | $51.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.21 |
| 52 Week Low | $2.96 | $0.81 |
| 52 Week High | $12.99 | $2.56 |
Technical Indicators
Market Signals| Indicator | NTHI | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 58.80 |
| Support Level | $3.03 | $1.38 |
| Resistance Level | $3.70 | $1.47 |
| Average True Range (ATR) | 0.42 | 0.09 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 15.74 | 91.82 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express. Geographically, the company operates in India, United States of America, United Kingdom, and China. It generates maximum revenue form India.